(a) Baseline characteristics
| Variable | Total (n = 267) | Patients without MACE (n = 226) |
Patients with MACE (n = 41) |
P value∗ |
|---|---|---|---|---|
| High risk (%) | 196 (73.4) | 157 (69.5) | 39 (95.1) | 0.001 |
| Age (year) | 49.3 ± 13.4 | 48 ± 13.7 | 56.4 ± 8.9 | <0.001 |
| Previous renal transplant (%) | 54 (20.2) | 45 (19.9) | 9 (22.0) | 0.765 |
| Smoking (%) | 117 (43.8) | 92 (40.7) | 25 (61) | 0.016 |
| Male (%) | 177 (66.3) | 147 (65.0) | 30 (73.2) | 0.311 |
| Diabetes (%) | 68 (25.5) | 50 (22.1) | 18 (43.9) | 0.003 |
| Hypertension (%) | 258 (96.6) | 219 (96.9) | 39 (95.1) | 0.561 |
| History of CAD (%) | 47 (17.6) | 30 (13.3) | 17 (41.5) | <0.001 |
| History of CVD (%) | 11 (4.1) | 5 (2.2) | 6 (14.6) | <0.001 |
| History of PVD (%) | 31 (11.6) | 19 (8.4) | 12 (29.3) | <0.001 |
| Statin (%) | 108 (40.4) | 91 (40.3) | 17 (41.5) | 0.876 |
| Renal replacement therapy | ||||
| HD (%) | 225 (84.3) | 187 (82.7) | 38 (92.7) | 0.120 |
| PD (%) | 21 (7.9) | 18 (8.0) | 3 (7.3) | |
| Preemptive (%) | 21 (7.9) | 21 (9.3) | 0 | |
| BMI (kg/m2) | 24.9 ± 4.9 | 24.9 ± 4.9 | 24 ± 7.4 | 0.743 |
| Mean time on dialysis before WL (mo) | 26.7 ± 41.8 | 23.7 ± 36.2 | 43 ± 62.6 | 0.002 |
| Mean followup after waitlisting | 55.3 ± 19.3 | 57.0 ± 17.7 | 45.8 ± 24.3 | 0.004 |
| Original renal disease | ||||
| Glomerulonephritis | 89 (33.3) | — | — | |
| Polycystic | 39 (14.6) | — | — | |
| Diabetic nephropathy | 32 (12.0) | — | — | |
| Vascular/hypertension | 27 (10.1) | — | — | |
| Unknown | 27 (10.1) | — | — | |
| Other | 25 (9.4) | — | — | |
| Reflux/pyelonephritis | 17 (6.4) | — | — | |
| Interstitial nephritis | 8 (3.0) | — | — | |
| Cancer | 3 (1.1) | — | — | |
| Deaths | 51 (19.1) | 31 (13.7) | 20 (48.8) | <0.001 |